Cite
HARVARD Citation
Kasner, S. et al. (2018). Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Lancet neurology. 17 (12), pp. 1053-1060. [Online].